ConductScience.org, home

Paper21800

Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium.

Bristow MR and 1 other. Eur J Pharmacol, 1977. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium. Papers, record 21800. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21800

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium.
PubMed
Journal
Eur J Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
2.29
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bristow MRM R
2Green RDR D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalciumMajor topic
DiazoxideMajor topic
GallopamilMajor topic
IsoproterenolMajor topic
Myocardial ContractionMajor topic
VerapamilMajor topic
Adrenergic beta-Antagonists
Animals
Dose-Response Relationship, Drug
Drug Interactions
Female
In Vitro Techniques
Male
Rabbits

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
6843691Interaction between calcium and slow channel blocking drugs on atrial rate.Naunyn Schmiedebergs Arch Pharmacol1983https://conductscience.org/library/papers/6843691PubMed
6738990Effects of dauricine on the dose-response relationship of isoproterenol and calcium and on the electro-mechanical activity in cat papillary muscles.Acta Acad Med Wuhan1984https://conductscience.org/library/papers/6738990PubMed
6329392Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.Br J Pharmacol1984https://conductscience.org/library/papers/6329392PubMed
6108142Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties.Br J Pharmacol1980https://conductscience.org/library/papers/6108142PubMed
3712517Effects of tetrandrine on various vascular smooth muscles.J Tongji Med Univ1986https://conductscience.org/library/papers/3712517PubMed
1383837Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.Naunyn Schmiedebergs Arch Pharmacol1992https://conductscience.org/library/papers/1383837PubMed
526260Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.Basic Res Cardiol1979https://conductscience.org/library/papers/526260PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21800

GET https://conductscience.org/api/papers/v1/21800/authors